For Development of Smart Vest Asthma Treatment
CPI is working alongside ItoM Medical BV and Blumorpho to support the development of a wearable medical device focused upon improving treatment for children with uncontrolled asthma. The device, a next generation smart vest prototype, will benefit from CPI’s expertise in the printable electronics sector.
Asthma is the most common chronic disease among children, with many suffering attacks and emergency hospital visits that lead to a decrease in quality of life and a subsequent increase in healthcare costs. CPI’s work with ItoM Medical aims to deliver a step-change in treatment by providing sufferers with the opportunity to take control of the disease and create a better life for themselves and their parents.
During the project, CPI will use its state-of-the-art technical capabilities to support the development of a working demonstrator of the device, bringing to the fore its experience in screen printing, attaching technologies for wearable electronics, and support to take products to pilot manufacture.
The project is also benefiting from utilising ItoM’s innovative surface-ElectroMyoGraphy (sEMG) technology, which, when attached to a flexible printed circuit and connected to the patient via a smart vest, is comfortable for the wearer and easy to operate in the home environment.
Blumorpho is working on the project by supporting the complex business needs for the legislative requirements and routes into the medical device market, developing a strong value proposition for the device across many EU healthcare systems.
The project is part of the wider SmartEEs programme, which is funded by the European Union’s Horizon 2020 Research and Innovation programme and aims to support companies with the development of new business ideas using flexible electronics technologies. This is being implemented through a Call for Application Experiments, with SmartEEs selecting and supporting 20 Application Experiments aimed at generating business success stories.
